713 related articles for article (PubMed ID: 28035582)
1. Endothelial Dysfunction and Hypertension.
Konukoglu D; Uzun H
Adv Exp Med Biol; 2017; 956():511-540. PubMed ID: 28035582
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction in hypertension.
Puddu P; Puddu GM; Zaca F; Muscari A
Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
Liu L; Liu J; Huang Y
J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
[TBL] [Abstract][Full Text] [Related]
4. Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly.
Rubio-Ruiz ME; Pérez-Torres I; Soto ME; Pastelín G; Guarner-Lans V
Ageing Res Rev; 2014 Nov; 18():132-47. PubMed ID: 25311590
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Treatment of Hypertension: Effects in Endothelial Function.
Cobos-Segarra L; Lopez-Jaramillo P; Ponte-Negretti Ci C; Villar R; Penaherrera E
Curr Hypertens Rev; 2018; 14(2):123-127. PubMed ID: 29737254
[TBL] [Abstract][Full Text] [Related]
6. [Endothelial dysfunction].
Nagy J; Csiky B; Kovács T; Wittmann I
Orv Hetil; 2001 Aug; 142(31):1667-72. PubMed ID: 11556260
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.
Shirakura T; Nomura J; Matsui C; Kobayashi T; Tamura M; Masuzaki H
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):831-8. PubMed ID: 27198514
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in essential hypertension.
Panza JA
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
[TBL] [Abstract][Full Text] [Related]
9. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
10. The role of statins in endothelial dysfunction in hypertension.
Sarkar K; Sinha AK; Mehta JL
Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent contractions and endothelial dysfunction in human hypertension.
Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
Br J Pharmacol; 2009 Jun; 157(4):527-36. PubMed ID: 19630832
[TBL] [Abstract][Full Text] [Related]
12. Targeting endothelial dysfunction in hypertensive subjects.
Thuillez C; Richard V
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in hypertension.
Vanhoutte PM
J Hypertens Suppl; 1996 Dec; 14(5):S83-93. PubMed ID: 9120689
[TBL] [Abstract][Full Text] [Related]
14. A rationale for treatment of endothelial dysfunction in hypertension.
Ruschitzka F; Corti R; Noll G; Lüscher TF
J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
[TBL] [Abstract][Full Text] [Related]
15. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation.
Silva IVG; de Figueiredo RC; Rios DRA
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337127
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial function and hypertension: insights and directions.
Dharmashankar K; Widlansky ME
Curr Hypertens Rep; 2010 Dec; 12(6):448-55. PubMed ID: 20857237
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension].
Semenkin AA
Ter Arkh; 2007; 79(4):31-8. PubMed ID: 17564015
[TBL] [Abstract][Full Text] [Related]
18. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.
Ivanovic B; Tadic M
Am J Cardiovasc Drugs; 2015 Dec; 15(6):403-14. PubMed ID: 26062915
[TBL] [Abstract][Full Text] [Related]
20. Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression.
Olatunji LA; Seok YM; Igunnu A; Kang SH; Kim IK
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1147-1157. PubMed ID: 27447455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]